Is Abbott Laboratories (ABT) Now Attractive After A 33% One Year Share Price Slide
- Wondering whether Abbott Laboratories at US$87.78 is starting to look interesting on valuation, or if the market still sees more downside risk than upside.
- The stock is up 0.4% over the last week but down 1.9% over the last 30 days, with year to date and 1 year returns declining 29.3% and 32.9% respectively, which puts recent moves in sharp contrast to longer term performance.
- These returns have kept Abbott Laboratories in focus alongside ongoing sector wide interest in healthcare companies, as investors reassess what they are willing to pay for stable earnings profiles. While there has not been a single headline driving the share price on its own, the stock continues to feature in broader discussions about defensiveness and pricing…
Source link
